Abstract
Novel technology allows for implantable neurostimulators (INS) to deliver therapeutic stimulation as well as record brain sensing information that can provide objective data to help optimize treatment. Local field potential (LFP) signals have been shown to be related to Parkinson’s disease (PD) symptoms, where LFP beta oscillations (13-30 Hz) tend to reflect rigidity and LFP gamma oscillations (48-200 Hz) tend to reflect dyskinesias1. A series of case studies were examined to detail in-clinic approaches to deep brain stimulation (DBS) programming that are informed by brain recordings of LFP.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Paper Title
Journal
Date
